Fakih Discusses Phase 2 Trial of Balstilimab Plus Botensilimab in MSS mCRC
February 3rd 2025Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for the treatment of patients with microsatellite stable metastatic colorectal cancer without liver metastases.
Preliminary Data Show the Potential of Balstilimab Plus Botensilimab in MSS mCRC
February 2nd 2025Marwan G. Fakih, MD, provides an overview of the study design, rationale, and findings from a phase 2 trial of balstilimab with botensilimab for the treatment of patients with microsatellite stable metastatic colorectal cancer without liver metastases.